FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
The purpose of the study is to evaluate if the exposure to all the three active cytotoxic agents (FOLFOXIRI regimen) is superior in terms of response rate to conventional chemotherapy with the FOLFIRI regimen as first-line treatment of metastatic colorectal cancer patients.
Epistemonikos ID: e19d9b608066dc48a7360d00b9f94206b9601464
First added on: May 06, 2024